Bottom line
How much do PJP and XPH overlap?
18% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 23.2% of PJP's assets and 10.6% of XPH's. They are substantially different portfolios, so owning both adds real diversification.
XPH holds far more positions (67 vs 33), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PJP and XPH have in common
| Holding | % of PJP | % of XPH | Overlap |
|---|---|---|---|
| Merck & Co., Inc. | 5.06% | 1.65% | 1.65% |
| Corcept Therapeutics Inc. | 4.96% | 1.70% | 1.70% |
| Amneal Pharmaceuticals, Inc. | 3.75% | 1.72% | 1.72% |
| Liquidia Corp. | 3.66% | 1.86% | 1.86% |
| Ligand Pharmaceuticals Inc. | 3.20% | 1.94% | 1.94% |
| Ocular Therapeutix, Inc. | 2.58% | 1.71% | 1.71% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PJP
- Invesco Private Prime Fund — 7.93%
- Abbott Laboratories — 5.67%
- AbbVie Inc. — 5.48%
- Amgen Inc. — 5.33%
- Johnson & Johnson — 5.18%
- Eli Lilly and Co. — 5.02%
- Gilead Sciences, Inc. — 4.53%
- Pfizer Inc. — 4.50%
- Invesco Private Government Fund — 3.73%
- Travere Therapeutics, Inc. — 3.30%
- Regeneron Pharmaceuticals, Inc. — 3.14%
- Harmony Biosciences Holdings, Inc. — 3.06%
- Bristol-Myers Squibb Co. — 2.94%
- Viatris Inc. — 2.83%
- Jazz Pharmaceuticals PLC — 2.79%
Only in XPH
- State Street Global Advisors — 8.58%
- Definium Therapeutics Inc — 3.09%
- MBX Biosciences Inc — 2.72%
- Alumis Inc — 2.14%
- AtaiBeckley Inc — 2.13%
- Trevi Therapeutics Inc — 2.12%
- Enliven Therapeutics Inc — 2.09%
- Amylyx Pharmaceuticals Inc — 2.04%
- VeraDermics Inc — 2.02%
- Nuvation Bio Inc — 1.89%
- Edgewise Therapeutics Inc — 1.88%
- Nektar Therapeutics — 1.88%
- Maze Therapeutics Inc — 1.85%
- Harrow Inc — 1.81%
- EyePoint Inc — 1.77%
Asset mix
| Asset type | PJP | XPH |
|---|---|---|
| Stocks | 99.9% | 100.0% |
| Cash & short-term funds | 11.8% | 8.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | PJP | XPH |
|---|---|---|
| US | 106.5% | 98.4% |
| IE | 5.2% | 3.0% |
| CA | — | 3.1% |
| GB | — | 1.6% |
| SG | — | 1.6% |
| KY | — | 1.0% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PJP and XPH overlap?
What stocks do PJP and XPH have in common?
Should I own both PJP and XPH?
Which holds more stocks, PJP or XPH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.